Please use this identifier to cite or link to this item:
Title: Guiding hypertension treatment with pharmacogenomics: the role of the community pharmacist
Authors: Pedro, Ana Luísa Lourenço da Silva de Oliveira 
Orientador: Simões, Sérgio Paulo de Magalhães
Keywords: Hipertensão; Farmacogenética
Issue Date: 2013
Abstract: Hypertension is a major risk factor for heart disease and stroke, which are the leading causes of death worldwide. Anti-hypertensive drugs account for the major drug class used in the treatment and prevention of cardiovascular diseases, although their use is based on a trial-and-error rationale. For anti-hypertensive drugs the percentage of non-responders can reach 20% of the patients under treatment, and non-compliance due to adverse drug responses is frequent. Among the causes known which account for differences in drug response are the interindividual genetic differences - the focus of study in Pharmacogenomics. Being able to provide Pharmacogenomic tests in a community pharmacy setting gives the pharmacist an opportunity to individualize drug therapy, maximising efficacy and minimising toxicity, based on patients’ genetic data. Given the number of hypertensive patients (circa 30% of global population), the expenditure with cardiovascular drugs (one million euros per day in reimbursements in Portugal) and the difficulty in finding the right drug for each patient, being able to offer Pharmacogenomic tests to hypertensive patients in a community pharmacy setting is an opportunity that should be seized.
Rights: embargoedAccess
Appears in Collections:UC - Dissertações de Mestrado
FFUC- Teses de Mestrado

Files in This Item:
File Description SizeFormat
Ana Luísa Pedro.pdf2.14 MBAdobe PDFView/Open
Show full item record

Page view(s) 10

checked on Nov 25, 2021

Download(s) 50

checked on Nov 25, 2021

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.